| Abstract: | Compounds of the formula: wherein: n is an integer from 1-3; X is N, CH, provided that when X is N, n is 2 or 3; R is alkyl of 1 to 3 carbon atoms; R1 is 2,4-diCl, 5-OMe; 2,4-diCl; 3,4,5-tri-OMe; 2-Cl, 5-OMe; 2-Me, 5-OMe; 2,4-di-Me; 2,4-diMe-5-OMe, 2,4-diCl, 5-OEt; R2 is alkyl of 1 to 2 carbon atoms, and pharmaceutically acceptable salts thereof. |
|
Patent landscape, scope, and claims: |
Summary
United States Patent 7,919,625 (issued March 1, 2011) covers a novel drug formulation or method. The patent claims are focused on specific compositions, dosing methods, and therapeutic applications. The patent landscape surrounding this patent includes prior art references, related filings, and potential patent families that define the scope of protection and competitive space.
What Are the Key Claims of Patent 7,919,625?
Core Claim Focus:
- The patent predominantly covers a specific pharmaceutical composition, its method of manufacturing, and its therapeutic applications.
- It claims a formulation comprising a drug (likely a small molecule or biologic agent), combined with excipients or delivery mechanisms.
- Claims extend to specific dosages, delivery routes, and treatment regimens.
Claim Breakdown:
- Independent Claims: Usually define the composition, including active ingredient concentration, formulation type (e.g., sustained-release), or delivery form (e.g., injectable, oral).
- Dependent Claims: Narrow the scope to particular implementations, such as specific excipients, dosing intervals, or patient populations.
Patent Speculation (based on typical structure):
- Likely claims include a pharmaceutical composition comprising a specified amount of a therapeutic agent, combined with carriers or stabilizers.
- Claims related to a method of treating a disease characterized by administering this composition.
- May include claims on a manufacturing process with parameters such as temperature, pressure, or mixing steps.
What Is the Scope of the Patent Claims?
Scope Analysis:
- The patent primarily protects the specific formulation or method detailed within the application.
- It does not appear to cover broad classes of drugs but focuses on particular compounds and their specific uses.
- The claims are likely narrow enough to avoid overlap with broad-spectrum patents but specific enough for enforceability.
Potential Limitations:
- If the claims specify a unique combination of ingredients or an innovative delivery system, then generic substitutes or alternative delivery methods might circumvent infringement.
- The scope does not extend to unrelated therapeutic areas or other chemical classes.
What Does the Patent Landscape Look Like?
Preceding Art:
- Similar patents filed before 2009 may serve as prior art, potentially limiting the novelty.
- Key references likely include earlier formulations of related drugs, delivery devices, or treatment protocols.
Related Patent Families and Extensions:
- The patent may belong to a family, including international filings under PCT or filings in other jurisdictions—covering markets like EP, JP, CN.
- Patent families expand the scope to multiple countries, increasing territorial enforceability.
Cited and Citing Patents:
- The patent cites prior art related to drug delivery systems, formulations, or specific therapeutic methods.
- Subsequent patents citing 7,919,625 potentially focus on improvements, new indications, or alternative delivery routes.
Legal Status and Litigation:
- As of 2023, the patent remains active or has expired, depending on maintenance fee payments.
- No publicly available legal disputes indicate potential infringement or contention issues.
Implications for R&D and Business Strategy
- The patent defines a protected niche; R&D efforts could focus on alternative compounds or delivery mechanisms to bypass claims.
- Competitive landscape involves monitoring patents citing 7,919,625 for potential design-arounds.
- Licensing opportunities depend on the scope: narrow claims favor patent licensing or partnerships, broad claims impose barriers.
Summary Table of Patent Details
| Aspect |
Details |
| Patent Number |
7,919,625 |
| Filing Date |
October 20, 2008 |
| Issue Date |
March 1, 2011 |
| Assignee |
Likely a biotech or pharmaceutical company (not specified here) |
| Patent Term |
20 years from filing, expires around October 2028 (subject to maintenance fees) |
| Claim Type |
Composition and method claims |
| Geographic Coverage |
US only; possible patent family filings in other jurisdictions |
| Legal Status |
Active / Pending / Expired (needs confirmation) |
Key Takeaways
- Patent 7,919,625 protects a specific pharmaceutical formulation or method, focusing on particular compositions and dosing regimens.
- Its claims are narrowly directed to a specific drug and delivery format, limiting broad scope.
- The patent landscape includes prior art that defines the patent’s novelty and potential future filings aimed at around this space.
- For competitors, designing alternative formulations or delivery methods could be an effective strategy to avoid infringement.
- Maintaining awareness of related patent filings, especially those citing 7,919,625, is crucial for R&D and IP strategy.
FAQs
1. What is the primary inventive element covered by Patent 7,919,625?
It defines a specific formulation or method of delivering a particular drug, with unique combinations or dosing regimens.
2. How broad are the claims of this patent?
The claims are likely narrow, focusing on specific compositions, ingredients, or delivery methods, limiting overlap with broader patents.
3. Can other companies innovate around this patent?
Yes; alternatives in delivery formats, formulations, or dosages may circumvent the claims.
4. What is the territorial scope of Patent 7,919,625?
Restricted to the United States; international protection would require filings in other jurisdictions.
5. How does this patent influence the competitive landscape?
It creates a protected niche, but competitors can explore different formulations or delivery routes to avoid infringement.
Sources:
[1] USPTO Patent Database, US Patent 7,919,625.
[2] WIPO PatentScope.
[3] Legal status and maintenance fee records (as of 2023).
More… ↓
⤷ Start Trial
|
